Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by DSEEGSon Aug 13, 2020 1:00pm
111 Views
Post# 31404044

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Acreage beat the expectations easily as well.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Acreage beat the expectations easily as well.
ilvmyt5s wrote:
What happened  to Acreages value to make it 4 x cheaper? Did Acreage reject the deal or did they just swallow it???


DSEEGS wrote:
Savage97 wrote: The transaction is expected means that it might not happen meanwhile Aphria's production facility is already constructed in Germany for a market that is double the size of Canada for medical alone which is covered by insurance.  GLTA



Like any deal their are risks associated with it . Every indication points to the trigger event happening soon. Getting the deal in place prior to laws changing is paramount . The price tags on MSO's will skyrocket as well as competition from others trying to  frantically get deals done makes for a crowded field . Its like reserving a table at the hottest restaurant on opening night versus trying to show up and hope to get served . 

Getting this leg up on the comp was why the market reacted so favorable to the deal . And on top of that Canopy recently restructured the deal which now is more than 4 times cheaper . 




That shows Canopy's strength and savvy. Canopy shareholders are thrilled with paying 4 x less . i fail to see the problem in that. .
<< Previous
Bullboard Posts
Next >>